Genmab A/S (CPH:GMAB)
1,690.00
-17.00 (-1.00%)
Apr 28, 2026, 4:59 PM CET
Genmab Employees
Genmab had 2,973 employees as of December 31, 2025. The number of employees increased by 339 or 12.87% compared to the previous year.
Employees
2,973
Change (1Y)
339
Growth (1Y)
12.87%
Revenue / Employee
7.96M DKK
Profits / Employee
2.06M DKK
Market Cap
103.75B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| Demant | 26,704 |
| H. Lundbeck | 5,039 |
| Zealand Pharma | 501 |
| Ambu A/S | 5,200 |
| Bavarian Nordic | 1,692 |
Genmab News
- 11 days ago - Genmab A/S Share Capital Reduction - GlobeNewsWire
- 14 days ago - Genmab Reports Strong Q1 DARZALEX Sales Near $4 Bln - Nasdaq
- 14 days ago - Major Shareholder Announcement - GlobeNewsWire
- 14 days ago - Genmab A/S: Genmab Announces Net Sales of DARZALEX (daratumumab) for First Quarter of 2026 - Finanz Nachrichten
- 14 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026 - GlobeNewsWire
- 14 days ago - Genmab Announces Net Sales of DARZALEX (daratumumab) for First Quarter of 2026 - Wallstreet:Online
- 15 days ago - Genmab (GMAB) Unveils Encouraging Data on New Ovarian Cancer Treatment - GuruFocus
- 15 days ago - Genmab A/S: Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S) in Combination with Bevacizumab in Advanced Ovarian Cancer - Finanz Nachrichten